Creafund supports the growth of Cooper Consumer Health

Creafund supports the growth of Cooper Consumer Health

Creafund supports the growth of Cooper Consumer Health

In October 2021, Creafund has reached a partnership agreement with Cooper Consumer Health, to support the company in its overall growth strategy. 

Cooper Consumer Health ("Cooper") is a leading pan-European pure-play selfcare platform with net sales totalling EUR 500m specialized in over-the-counter drug manufacture and distribution. The group has direct presence in 6 core European markets and addresses more than 30 export countries where it markets a wide portfolio of well-established brands such as Valdispert®, Oenobiol®, Mag2®, Etiaxil®, etc. Cooper employs 850 people. As the next step in its growth strategy, Cooper has agreed to acquire the French nutraceutical company Lashilé Beauty, the market-leader in the fast-growing gummy dietary supplement category in France. The business fits well the bolt-on strategy of Cooper, with a complementary product portfolio with attractive underlying growth, a scalable business model that can be rolled-out internationally, and strong online and digital marketing know-how.

This website uses cookies The website of Creafund Asset Management nv uses functional cookies. In case of analysing our traffic or advertising, we also place cookies that share information about your use of our site with our analytics partners, our social media and advertising partners, who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
Show details Hide details
Allow selection Allow all cookies